The study presents the use of a continuous crystallization device that can be directly incorporated into flow chemistry setups. Inside this device spontaneous nucleation and growth of organic molecules are controlled and maintained, using Aspirin as model molecule. The identification of the optimal crystallization scenario is discussed in view of the chemical stability of Aspirin and based on the determination of the solubility and the metastable zone width corresponding to the presented experimental setups. Physicochemical analyses combined with heat transfer modeling of the solution whilst flowing through a capillary placed inside a thermostated water bath provide the desired cooling profile and hence the degree of supersaturation along the system. The crystalline quality and stability of the crystalline output is evidenced for two different pump setups having distinguished flow patterns to show the independence on the flow stability, an important parameter for the success rate of the complete reaction scheme and in the perspective of operation scale-up. Reproducible output of material with narrow size distributions is obtained throughout all experiments.
Introduction
Crystallization is the last step in the production of almost all active pharmaceutical ingredients or API [1] . As such, it is an integral part of the complete API production scheme consisting of all necessary chemical reactions and unit operations. It is therefore necessary that, next to other unit operations such as solvent exchanges, liquid-liquid reactions and others, valid crystallization alternatives exist that can be readily incorporated into flow chemistry streams [1, 2] . Albeit not a chemical transformation operation, continuous crystallization must be regarded as a full and integral part in the flow chemistry domain. Continuous crystallization from solution of small molecular weight organic molecules has known an increased interest following a trend to convert chemical production processes of these molecules from batch conditions to continuous flow operations [1, 3, 4] . Different approaches exist to achieve continuous crystal output such as Mixed Suspension Mixed Product Removal (MSMPR), oscillatory baffled crystallizers (OBC), as well as tubular reactors [5] [6] [7] [8] [9] [10] [11] [12] .
Many of the used continuous crystallization methods follow one main rule: spontaneous nucleation is, besides some exceptions [13, 14] in most cases avoided [5, [15] [16] [17] [18] [19] . The main reason is the lack of control of the suitable conditions, so that nucleation gets out of hand resulting in retrieved cakes inside the reactors [20] . The use of milli-and micro-metric tubular reactors to perform crystal nucleation may overcome this drawback as residence times at nucleating conditions are drastically reduced; despite the reached high supersaturation values that ensure high nucleation rates [21, 22] .
Besides, both theoretical and experimental evidences point out that shear rates have an influence on the nucleation behavior [23] . Tests performed in Couette flow conditions by Forsyth and coworkers show an increased nucleation rate as a function of average shear rate inside a tubular reactor [24] . We demonstrated recently that the application of specific flow structures by using capillary tubing and high flow velocities result in high nucleation rates while a solution is cooled down to the supersaturated state [21] . These experimental data to reach enhanced nucleation rates were obtained for the Active Pharmaceutical Ingredient Brivaracetam and demanded generalization using other molecules. Acetyl salicylic acid or Aspirin was opted as molecule of choice as it has been widely investigated for its crystallization behavior [25] [26] [27] [28] [29] . A mixture of ethanol and water is used as solvent system. The combination of Aspirin with this solvent system has a large spectrum in solubility values between 0°C and 100°C and was therefore considered as a suited candidate to undergo a spontaneous nucleation study [30] . This paper focuses on the development of the crystallization process inside a tubular nucleator. The aim is to obtain steady-state operation using two different pumps and flow circuit setups. Estimations of the nucleation rates are done and allow to quantify the capabilities of the current proposed crystallization device.
Experimental
Aspirin was purchased from Sigma-Aldrich, absolute ethanol of 99+ % purity from VWR, both were used as such. Distilled tap water was used.
Solubility of Aspirin in different mixtures of ethanol and water was measured. For all datapoints a fully saturated mixture of Aspirin in a given ethanol/water blend was prepared, set at given temperature and stirred for 7 days. Afterwards, a sample of the liquid phase was taken and weighed. After 3 days of drying at 60°C the solid content was weighed and the amount of solids per mL solvent calculated. Each condition was repeated three times. All concentrations are noted as mg Aspirin per mL of solvent, namely mg.mL −1 . Note that the chemical stability of aspirin in the liquid phase, namely its decomposition into salicylic acid and acetic acid, might give rise to an underestimation of the total weight retained after drying, as acetic acid will evaporate. As we are only interested in solubility values at low temperatures where this hydrolysis is less important, a maximum deviation of 10% of the absolute solubility value have been observed.
For crystallization tests, Aspirin solution was prepared and put in a furnace at 65°C for 17 h. Both crystallization setups consist of a 2 L agitated and heated reservoir connected to a stainless steel fluidic system. In the first setup, assigned as "damper" setup, the solution is pumped at a flow rate of 30 mL.min −1 by a Prominent Sigma 2 pump out of the vessel, through heated stainless steel 1/4″ outer diameter tubing. This tubing is connected with a 0.32 mL hydraulic damper. The straight tubing line is coupled to the tubular crystallizer. The pump operates at 1 Hz, the sample chamber volume is adjusted to 0.51 mL, so that 30.6 mL.min −1 is pumped through the lines.
In the second setup, assigned as "back pressure regulator", or in short "BPR" setup, the stainless steel tubing makes a loop back into the heated vessel. Inside this loop, two manual back pressure regulators are incorporated, as sketched in Fig. 1 . The first, BPR 1, adjusts the pressure in between the pump head and BPR1 for correct liquid uptake by the pump. BPR 2 generates a slightly higher pressure in between BPR 1 and BPR 2 than in the tubing downstream, and allows both a by-pass of liquid back into the heated vessel and liquid sampling towards the tubular crystallizer at the desired flow rate. The membrane pump, a Prominent Sigma 1 pump, is set to operate at a frequency of 1 Hz, using its full chamber capacity of 3.2 mL. This results in a total flow inside the loop of 192 mL.min −1 . By regulating the pressure difference between BPR 1 and BPR 2, the sampling rate can be adjusted and calibrated as such that an average flow rate of 30 mL.min
The tubular crystallizer consists of a 3 m long perfluroalkoxy (PFA) plastic tubing of 1 mm inner diameter (ID) and 1/16″ outer diameter using Swagelok and plastic Upchurch connectors to be coupled to the stainless steel setup. This tubing is placed entirely inside a cooled water bath, with at both ends tubing standing out to make the connection and to enable sampling at the flow exit.
The difference between both setups lies in the fact that for the "damper" setup, the flow profile is heavily smoothened and can be regarded as constant. On the other hand, in the "BPR" setup the 1 HZ stroke to empty the pump membrane chamber is not fully damped and as a consequence a sinusoidal flow profile is introduced. To obtain 15 mL samples, slurry is collected during 30 s inside a flask. The slurry is maintained at room temperature until saturated conditions are reached inside the flask. This takes typically a maximum of 30 min after sampling, depending on the tested conditions. The slurries are then filtered and dried at room temperature during 24 h. Note that the chosen flow rate remains unchanged throughout the paper to reduce the amount of variables; for a true optimization of the end-product after crystallization, the influence of flow rate on the nucleation rate should be investigated; 30 mL.min −1 is however regarded as a good starting point as it resulted in high nucleation rates for Brivaracetam [21] . Average nucleation rates J for samples that are set to crystallize to the saturation conditions can be calculated using the following relation:
With C s is the used Aspirin concentration, C* is the solubility value at the set growth temperature T G , V crystal is the average volume of one crystal, ρ c is equal to 1.4 g.cm −3 , which is the density of Aspirin crystals, and τ expresses the sampling time for current setup and is equal to the collecting volume divided by the flow rate expressed in mL per second. The equation for J results in an amount of crystals produced per second per milliliter solution, when the difference in density between solvent and solution at temperature is neglected. Aspirin crystals appear as flat rectangular flakes, their volume V crystal is therefore considered to be averagely equal to the product of their length per width per height. Note that any existing Ostwald ripening effect is incorporated into this procedure as only the crystal volume at saturated conditions is considered. For its evaluations, V crystal is analyzed individually per crystal and then an average volume is calculated. Values for J are always rounded to the thousand as this value represents only a rough estimation of the amount of crystals produced per unit of volume and time.
Metastable zonewidth (MSZW) analysis was performed at nucleation temperatures T N equal to 0 and 10°C, using the "damper" crystallization setup as described above. Starting at a low concentration the system ran for several minutes, a total of 4 samples of 15 mL each were taken. The samples were kept at growth temperature T G during 24 h. When no crystals appear, a new test was run under identical conditions using an increased concentration. The metastable zonewidth was reached when the 4 samples crystallized over time; iterations were performed to refine the position of the MSZW to be precise to about 12.5 mg.mL −1 variation.
All thermophysical tests were performed on dissolved Aspirin in a 50/50 vol% mixture of ethanol and water and with a concentration of 200 mg.mL
. Solution density was measured with an Anton-Paar DMA-4500 M densimeter, between 65 and 20°C using intermediate steps of 5°C. Heat capacity measurements were performed on a Mettler-Toledo 822e Differential Scanning Calorimeter; a heating rate of 10°C.min −1 was applied for reference, sapphire calibration and sample tests. The experiments were performed using 5-10 mg of sample in 85 μL aluminum pans. Thermal conductivity was measured using a Hot Disk TPS 2500S at 60°C by plunging the sensor in the middle of 50 mL of solution, held at temperature. These data are then introduced into a COMSOL simulation for evaluating the heat transfer in a laminar liquid flow through a tubing that sits inside a static water bath, as we have previously described [21] . X-ray diffractometer (XRD) spectroscopy experiments on filtered and dried particles were performed on a Bruker D5000 diffractometer using a graphite monochromator and Cupper source (κ = 1.5406 Å).
Step time was set at 3 s with 0.02°2θ as step. Crystalline powder samples were placed as such in the sample holder; samples on filters were clamped to obtain a flat surface.
A calibrated polarized light Nikon microscope in birefringent mode, equipped with a Zyla camera, was used for crystal habit and size evaluation in 2 dimensions, length and width, of filtered and dried samples. For all samples 200 clearly individual crystals were analyzed.
For an estimation of crystal height a Keyence profilometer VK X-100 was used to compare crystal height to crystal width. In total 100 crystals of different crystallization tests were analyzed, crystal height was on average equal to 1/6th of the crystal width; this value was used for nucleation rate calculation.
Results and discussion
The thermal stability of aspirin
The thermal stability and decomposition behavior of Aspirin is a known issue [29] [30] [31] [32] [33] . The presence of water makes Aspirin slowly decay into salicylic acid. It was found that Aspirin could be dissolved in the ethanol/water mixture at Fig. 1 Crystallization test setups used in the current study. (Above) "damper" setup using a straight connection between pump and crystallizer tubing. (below) "BPR" setup using a liquid by-pass loop from which liquid is continuously sampled towards the tubular crystallizer. On the right hand the schematic representation of the flow rate profiles per pump stroke for both setups. BPR stands for back pressure regulator elevated temperatures overnight with a controlled decomposition. This is proven by the X-ray Diffraction (XRD) spectrum in Fig. 2 where fresh Aspirin was dissolved in ethanol/water overnight and immediately used for a crystallization test. The NIST library spectrum of Aspirin, in blue, nicely overlaps. When recycled Aspirin from previous tests was used, only salicylic acid was retrieved in the XRD spectra, see Fig. 2 (below) . To make sure all data discussed in the paper originated effectively from Aspirin, all retrieved crystals were analyzed with XRD, and no recycled Aspirin was used.
Next to that, 1 H-NMR analyses were performed as function of time on Aspirin/D 2 O/EtOH-d samples set at 65°C. After 17 h, a decomposition between 24 and 26% is obtained. Therefore, as all crystallization tests are performed after exactly 17 h of dissolution, nearly identical decompositions can be assumed for the different sample sets. For clarity, the initially weighed sample concentrations will be used throughout the paper. Since all further shown crystalline products are determined at least 99% pure, the current proposed method is capable of purifying out impurities. 
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Determination of the crystallization parameters
The solubility of Aspirin for a wide range of mixing ratios of ethanol and water presents an identical behavior: low solubility values at low temperatures and an exponential increase in solubility starting from 50°C and higher. Figure 3 shows the measured solubility of Aspirin in the 50/50 vol% ethanol/water blend, orange line.
The following relationship between solubility value C* and Temperature T C* (in Kelvin) was found using a Van't Hoff approximation; with a correlation coefficient R 2 of 0.997:
with C 0°C the concentration at 0°C and T 0°C the corresponding temperature in Kelvin, thus 273.15 K. All values show good agreement with previously measured data in literature [31] . The solubility behavior of Aspirin in this 50/50 vol% mixing ratio between ethanol and water can be regarded as a good starting point for a spontaneous nucleation study. Upon cooling of an undersaturated solution to lower temperatures it will eventually cross the solubility line, the saturated state. At lower temperatures the liquid stands out of equilibrium, i.e. supersaturation, gauged by the supersaturation parameter σ, defined as [34] 
In order to spontaneously nucleate, a certain threshold in supersaturation has to be overcome [34, 35] . This threshold value is commonly referred to as the metastable zonewidth or MSZW. As this zone is defined by kinetic variables such as for instance residence time and cooling rate, it is crucial to use identical test parameters. The performed MSZW analysis, plotted as the blue points in Fig. 3 , shows that at a nucleation temperature T N equal to 0 and 10°C Aspirin starts to crystallize at initial concentrations of 162.5 and 175 mg.mL −1 , respectively in the 50/50 vol% mixture of ethanol and water. Therefore, a concentration of 200 mg.mL −1 (Fig. 3, grey dot) , is regarded as a suitable condition for the spontaneous nucleation and crystallization tests at T N = 10°C. The calculated temperature of the liquid solution along both the centerline and tube wall immersed in a static water bath held at 10°C is plotted in Fig. 4 ; σ evolution, green curves Fig. 4 , is calculated as a function of the tube length using temperature and solubility values from Fig. 3 . Calculations are based on the methodology developed in a previous work [21] . While cooling inside the tubular crystallizer, the solution temperature drops and saturation is reached after a short distance, indicated by the orange points in Fig. 4 , calculated using Eq. . This value corresponds to a supersaturation value for the MSZW (σ MSZW ) of 5.7. After collection, the samples are held at a growth temperature T G = 25°C until saturation conditions are reached. Therefore, any nucleation will eventually result in a concentration drop of the slurry below the MSZW. It is therefore expected that nucleation is absent after sample collection.
Indeed, a test sample of this 200 mg.mL −1 solution of Aspirin was cooled down from 65°C to 25°C, by placing 15 mL solution inside a test tube at 25°C -static conditions. No Drying at ambient temperature Several days crystallization was observed during a period of 30 days, after which the experiment was stopped. As expected, at selected T N = T G = 25°C, a liquid with a 200 mg.mL −1 concentration has not overcome the MSZW for bulk conditions. Therefore, it can be stated that all crystals shown further are created during their cooling phase, inside the tubing.
Interpretation of crystallization tests
Crystallization tests were performed using the parameter set shown in Table 1 for both test setups. At the start, the system needs to be pressurized to obtain stable flow rates, this takes about 7-8 min to guarantee stable operation of several minutes prior to sampling for both setups. For one single condition multiple samples are taken with at least 4 min full operation of the system in between each collected sample. As a consequence, the system runs continuously in crystallization conditions up to a total of at least 30 min at one time for the damper setup. Longer tests can be performed using the BPR setup, as the pump feeds continuously the liquid inside the loop. When the desired test condition is reached, for example the water bath reaches a certain T N , the tubular crystallizer is plunged into the water bath. Afterwards samples are taken with 4-5 min time intervals. After this is done, the tubing is taken out of the water bath and a new test condition can be programmed. The system can run in these conditions for several hours without noticeable issues. It has to be stated however that during actual crystallization tests clogging may occur at the end of the tubing due to sticking crystallizing droplets at the outlet of the tubing when the tubing is held constantly in air. This is due to the fast crystallization conditions and the wettability between the solution and the tubing making droplets to stick to the wall. In between sampling, the outlet of the tubing is immersed in an unsaturated mixture of ethanol/water, to effectively prevent this phenomenon. For this work, samples were gathered and set to grow in 15 mL large vials. The growth to equilibrium is necessary to obtain insights in the nucleation rate. However, for industrial applications, shorter residence times to obtain smaller particles or different growth regimes can be envisaged whether it is in a batch like or tubular environment, or directly casted on continuous operated filters with some residence time to let the crystals grow to a certain, desired, size.
Four samples of Aspirin crystallized using the damper setup with the conditions as set out in Table 1 are presented, one microscopic image per test is shown in Fig. 5 , all measured sizes are shown in Table 2 . A four-minute gap of continuous operation at crystallization conditions is respected in between each sample collection. For the different sampling times, average length remains in the same size range with comparable standard deviation. The crystal width varies more in between the different samples, hence also the observed variation in nucleation rates. The spread in size is also expressed by the d 90 Fig . 6 Crystal length distribution for the four tests for Aspirin crystallization using the damper setup as shown in Table 2 for a total of 200 crystals analyzed per sample For the four samples span values around unity are obtained indicating that a narrow size distribution, at least according to industrial standards, is obtained. Moreover, the histogram of occurring crystal lengths in Fig. 6 of the four presented samples show large similarities. It can thus be stated that the production of crystals is stable over time as the collection of these samples occurred over a period of about 15 min, plus 8 min start-up time. Nucleation rates of the order of tens of thousands crystals produced per second and per milliliter are obtained.
In Table 3 and Fig. 7 the crystallization results and crystal length distributions are presented for the crystallization tests performed with the BPR setup at a nucleation temperature T N = 10°C, identical to that used for the previous set of experiments performed with the damper setup. Apparently, both crystallizer setups running at T N equal to 10°C show similarities. The results are to be considered invariant as a function of time: average lengths and width values for both the BPR and damper setup are comparable to each other. Also, the crystal length distributions show same tendencies as a function of size ranges. The nucleation rate J has a larger deviation in between the samples for the damper setup as compared to the BPR setup. It appears that average width is, although less stable, smaller in the damper setup. This indicates that for a given flow rate, independently of the flow profile, the tubular crystallizer setup generates a stable output of material, with constant crystalline product quality and narrow particle size distribution as all measured span values are around unity. As such, in Table 4 the data originating from the four individual samples taken per test conditions are joined into one single dataset for which 800 individual crystals were analyzed. In this table, the different tested T N are shown using the BPR Fig . 7 Crystal length distribution for four tests for Aspirin crystallization using the BPR setup at T N equal to 10°C as shown in Table 2 for a total of 200 crystals analyzed per sample 
T N = 30°C initial solution through the tubing is reached and could be added to the MSZW line in Fig. 1 . As can be observed in Fig. 8 very large crystals are obtained. It is quite remarkable that the samples nucleated at a temperature of 15°C have the lowest average values and therefore outstanding nucleation rate, also the microscopic images of Fig. 8 show high quality crystals for this test as compared to the tests with T N equal to 10 or 20°C. Comparing the crystal length distributions, it appears that this sample has a reduced tail of larger crystals; which lowers the average value quite drastically. At the moment there is no valid insight for this effect. At increasing nucleation temperatures, the average crystal sizes and the maximum occurrence in the histograms increase in a logical way, up to the point that the MSZW is reached at 30°C. Note that in static conditions and identical concentration at T N equal to 25°C no crystallization occurs. This indicates that the kinetics of nucleation is lowered by the mere fact that the product has been flown through the PFA tubing. The influence of flow, flow rate, interactions with the tube wall, applied shear rates or others on nucleation and nucleation kinetics is therefore to be considered as highly important and demand further investigation. Moreover, this effect already renders the production of small crystals at low supersaturation levels, especially when compared to the MSZW width. Next to this, all tests performed with concentrations of 200 mg.mL −1 and T N of 10°C are at this temperature already very close to the MSZW value. As a matter of fact, the disappearance of 25 mg aspirin per mL solvent during nucleation and the first stages of growth is sufficient to leave the spontaneous nucleation zone and no more nucleation can occur. Therefore after gathering the material it is expected that no further nucleation will occur, besides the nuclei formed in the tubing.
Conclusions
Aspirin is successfully crystallized inside two different tubular crystallizer setups using a flow rate of 30 mL.min −1 and a solvent mixture ethanol/water of 50 vol%. The continuous production of crystals is not affected by the flow profile induced by the different pump systems pointing out the stability of the chosen crystallization setup. The crystal output results in a constant size distribution over time; indicating that a steady-state production can be achieved over long periods of operation. Span values around unity are obtained indicating narrow particle size distributions. Changes in nucleation temperature result in a crystalline product of different size while maintaining a high-quality crystalline product with a small particle size distribution as is demonstrated throughout the paper with small span values for all measured samples. The crystallization procedure is also capable of purifying the solution, as all residual salicylic acid, a product of the gradual hydrolysis of aspirin at high temperature, is absent in final retrieved crystalline products. As such, over 10% impurity is removed in between the solution and the final crystalline product. Table 4 It is also found that the metastable zonewidth is lowered in flowing conditions using proposed setups as compared to static conditions. This indicates that nucleation kinetics is drastically influenced under flow, even at low supersaturation levels; even more pointing out the importance of conducting spontaneous nucleation inside narrow tubular crystallizers.
